• CureVac Appoints Dr. Malte Greune as COO contractpharma
    July 01, 2021
    CureVac N.V., a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), has appointed Dr. Malte Greune as chief operating officer (COO) effective July 1, 2021.
PharmaSources Customer Service